Definitely its not only this product which they are going to aggressively promote worldwide in July/August but it is also the next product in the pipeline.
The numbers there are staggering, just in the US then when the numbers are extrapolated to the world at large, have a winner already in Phexxi, but, I think more than myself see this as a winner winner chicken dinner opportunity and agree that will end in buyout when that horse it let out of the barn.
Always happens with smaller biotechs especially when they have a number of winners in a sector of the market. Bigger companies can cut costs in every aspect which is why they gobble up these smaller players.
News 
Market Data 
Discover 
